Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study.
about
The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjectsInvestigational agents for the management of Huntington's disease.The monoamine stabilizer (-)-OSU6162 counteracts downregulated dopamine output in the nucleus accumbens of long-term drinking Wistar rats.The Effects of the Monoamine Stabilizer (-)-OSU6162 on Binge-Like Eating and Cue-Controlled Food-Seeking Behavior in Rats.A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome.
P2860
Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Tolerability and efficacy of t ...... double-blind cross-over study.
@en
Tolerability and efficacy of the monoaminergic stabilizer
@nl
type
label
Tolerability and efficacy of t ...... double-blind cross-over study.
@en
Tolerability and efficacy of the monoaminergic stabilizer
@nl
prefLabel
Tolerability and efficacy of t ...... double-blind cross-over study.
@en
Tolerability and efficacy of the monoaminergic stabilizer
@nl
P2093
P2860
P356
P1476
Tolerability and efficacy of t ...... double-blind cross-over study.
@en
P2093
Angelica Kloberg
Arvid Carlsson
Jan Wahlström
Maria Lizzie Carlsson
Marie Karin Lena Nilsson
Radu Constantinescu
Sara Haghighi
P2860
P304
P356
10.1017/NEU.2014.16
P577
2014-10-01T00:00:00Z